
Product Information
- AM1638
- (βS)-β-Cyclopropyl-3-[[2-(5,5-dimethyl-1-cyclopenten-1-yl)-2′-fluoro-5′-methoxy[1,1′-biphenyl]-4-yl]methoxy]benzenepropanoic acid
- Benzenepropanoic acid, β-cyclopropyl-3-[[2-(5,5-dimethyl-1-cyclopenten-1-yl)-2′-fluoro-5′-methoxy[1,1′-biphenyl]-4-yl]methoxy]-, (βS)-
- AM 1638
AM-1638 is an orally active GPR40/FFA1 agonist, useful for studying type II diabetes.
Chemical properties
Technical inquiry about: TM-T14200 AM-1638
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.